Can be great, but be careful - Director Quality bei Merck: Mitarbeiterbewertung

3,0
6. Feb. 2024
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great people, good opportunities to volunteer.

Kontras

Different divisions are like entirely different companies; some management is amazing, but some are brutal (severely incompetent with big egos, but somehow protected). With recent policy changes and layoff strategy, pretty clear that in 2024, they’re focused on cutting cost and don’t have a lot of value for their more experienced employees.

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle